Beck Bode’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.1M Buy
76,093
+1,173
+2% +$309K 3.15% 11
2026
Q2
$19M Buy
+74,920
New +$17.5M 2.88% 14
2023
Q3
– Sell
-5,981
Closed -$990K – 137
2023
Q2
$990K Buy
5,981
+7
+0.1% +$1.13K 0.24% 96
2023
Q1
$926K Buy
5,974
+3,073
+106% +$496K 0.23% 100
2022
Q4
$512K Sell
2,901
-4,738
-62% -$818K 0.12% 123
2022
Q3
$1.25M Buy
7,639
+1,767
+30% +$299K 0.27% 83
2022
Q2
$1.04M Sell
5,872
-7,657
-57% -$1.36M 0.22% 87
2022
Q1
$2.4M Buy
13,529
+12,318
+1,017% +$2.1M 0.54% 43
2021
Q4
$207K Sell
1,211
-159
-12% -$26K 0.05% 86
2021
Q3
$221K Buy
1,370
+148
+12% +$25.2K 0.06% 81
2021
Q2
$201K Buy
+1,222
New +$202K 0.06% 75
2020
Q4
– Sell
-883
Closed -$131K – 144
2020
Q3
$131K Buy
+883
New +$131K 0.05% 70
2019
Q1
– Sell
-7,731
Closed -$998K – 75
2018
Q4
$998K Buy
+7,731
New +$1.08M 0.54% 44

Other funds holding JNJ

Beck Bode's JNJ Position: Q3 2026 in Review

Beck Bode increased its Johnson & Johnson (JNJ) stake by 1.6% in Q3 2026, buying an estimated $309K and bringing the position to 76,093 shares worth $20.1M. The position accounts for 3.15% of the portfolio, ranked #11.

Beck Bode first reported a position in JNJ in Q4 2018 and has held it in 13 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Beck Bode held 76,093 shares of Johnson & Johnson worth $20.1M as of Q3 2026.
  • Beck Bode bought 1,173 Johnson & Johnson shares in Q3 2026, an estimated $309K.
  • Johnson & Johnson made up 3.15% of Beck Bode's portfolio in Q3 2026, its #11 holding.
  • Beck Bode first reported a position in Johnson & Johnson in Q4 2018 and has held it in 13 quarters since.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.